AudioScholar Rheumatology Weekly (India)

Welcome to This Week in Rheumatology. This week we are covering eight notable papers spanning advances in spondyloarthritis diagnosis and tracking, the genetic and therapeutic landscapes of giant cell arteritis, and emerging tools to predict complica… This week's papers: 1. Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project —...

Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning predicting and preventing disease progression in psoriatic arthritis, cardiorenal management in systemic autoimmune diseases, and novel clinical tools for patie… This week's papers: 1. Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights fro...

Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning emerging cellular and molecular targets in systemic autoimmune diseases, real-world evidence and imaging in inflammatory arthritis, and system-level insights in… This week's papers: 1. Predictors of rapidly progressive interstitial lung disease in anti-MDA5 dermatomyositis: a meta-analysis — Rheumatology (Oxf...

Welcome to This Week in Rheumatology. This week we're covering 8 notable papers spanning advances in precision monitoring and biomarkers, new insights into long-term risk and disease pathogenesis, and a look at novel therapeutics in related fields. L… This week's papers: 1. Talquetamab-Daratumumab in Relapsed or Refractory Myeloma. — The New England journal of medicine 2026 2. Interleukin-10 Autoa...

Welcome to This Week in Rheumatology. This week we're covering 6 notable papers spanning risk stratification in systemic autoimmune diseases and new insights into disease pathophysiology. Let's dive in. A central challenge in managing systemic rheum… This week's papers: 1. Pulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs356774...

Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning new therapeutic breakthroughs in systemic diseases like lupus and polymyalgia rheumatica, a refinement of our approach to common conditions like osteoarthritis,… This week's papers: 1. Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial. — JAMA 2026 2. Ph...

Welcome to This Week in Rheumatology. This week we're covering 9 notable papers spanning new therapeutic paradigms like CAR-T cell therapy [7], optimizing treatment in challenging populations like lupus nephritis [3] and elderly vasculitis [4], and i… This week's papers: 1. Genomic instability drives POSTNmyofibroblasts via STING-WNT axis to promote immunosuppression and PARPi resistance in ovaria...

Welcome to This Week in Rheumatology. This week we're covering 8 notable papers spanning several key areas, including new therapeutic strategies for diseases like Sjögren's and GCA, ways to optimize outcomes in psoriatic arthritis and RA-associated l… This week's papers: 1. Resetting autoimmune disease with CAR cell therapies — Nature medicine 2026 2. Treatment strategies in giant cell arteritis a...

Welcome to This Week in Rheumatology. This week we're covering 8 notable papers spanning early intervention strategies, the fundamental mechanisms of autoimmunity and fibrosis, and new data on lupus therapies. Let's dive in. [PAUSE] Our first theme… This week's papers: 1. Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a random...